AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

On supercomputers and life sciences, listening to Treasury naysayers risks letting work and political capital slip away ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

Prime Minister Keir Starmer said it was a “commercial decision” by a major international biopharmaceutical firm to pull out ...

Science minister Sir Chris Bryant said the Government feels regretful about the plan being ditched and ‘would prefer to have ...

and that the deal failed to "demonstrate value for the taxpayer". AstraZeneca is the second multinational to blame the new government for a withdrawal of investment. Two months ago Vauxhall owner ...

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the ...